News
on
|
Research Feature
They ranged in age from 15 to 61—four African American women, all with stories to tell about their struggles with sickle cell disease, all with stories about a common experience that helped them through those struggles: participating in clinical trials. It mattered, said the women, all of whom had joined trials funded by the National Institutes of...
|
Research Feature
The notion of altering a person’s genes to cure disease used to be the stuff of science fiction. But gene editing experiments aimed at the genetic disorder that causes sickle cell disease are now making their way from the laboratory to clinical trials. And researchers supported by the National Heart, Lung, and Blood Institute (NHLBI) are hoping tho...
|
Research Feature
Jennifer Nsenkyire (pronounced ‘century’) has suffered from sickle cell disease for as long as she can remember. As a teenager growing up in her native Ghana, she endured the excruciating pain caused by the condition sometimes for days at a time. At least once a month she had to be hospitalized, and blood transfusions came at a steady, troubling pa...
|
News Release
A sickle cell anemia study has found that the drug hydroxyurea is as effective as blood transfusions in children to reduce blood flow velocities in the brain, which is a key risk factor for stroke. The findings appear in The Lancet and were presented at the annual meeting of the American Society of Hematology. Some children living with sickle cell...
|
News Release
WHAT : An analysis by National Institutes of Health researchers has shown that people with sickle cell anemia who took the drug hydroxyurea at the recommended dose had higher survival rates than those who took less than the recommended dose. The findings appear in the journal PLOS ONE. Researchers at the National Heart, Lung and Blood Institute (NH...
|
Research Feature
DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Announcement of Requirements and Registration for “Novel, Innovative Tools to Increase Public Awareness and Knowledge of Sickle Cell Disease Undergraduate Challenge” Authority:15 U.S.C. 3719 Agency: Department of Health and Human Services (HHS), National Institutes of Health, Nat...
|
Research Feature
NHLBI Director Dr. Gary H. Gibbons recently sat down to discuss sickle cell disease and research advances into the condition with radio host Willie Moore. Below is a transcript of the interview: Dr. Gary H. Gibbons Radio Interview with Nightly Spirit with Willie Moore Your browser does not support the audio element. Dr Gibbons Willie Moore Trimmed....